RESUMO
BACKGROUND: Eating disorders have been described as possible 'culture-bound syndromes', with roots in Western cultural values and conflicts. They may, in fact, be more prevalent within various non-Western cultural groups than previously recognised, as Western values become more widely accepted. Cross-cultural experiences suggest that cultural change itself may be associated with increased vulnerability to eating disorders, especially when Western values about physical aesthetics are involved. OBJECTIVE: to assess the eating attitudes and behaviours among adolescents in the urban ethnic city, Mumbai, a survey was conducted amongst 451 college students. METHOD: the study, based in four junior colleges, comprised 451 subjects who completed a semi-structured questionnaire, a 26-item Eating Attitudes Test (EAT-26) and the Personal Assessment Inventory (IPAT). RESULTS: the results revealed faulty eating habits in 13.3% of the subjects. A statistically significant proportion perceived them-selves to have problems with eating, substance use, dieting and exercise practices, resorting to extreme measures to achieve weight loss. A high rate of faulty eating habits was observed in males. Higher scores on depression and suicidal ideation were reported in the population with faulty eating habits. CONCLUSION: a significant percentage of college-going populations in urban settings probably have faulty eating habits.
RESUMO
OBJECTIVE: Although still controversial, as early as 1989, the World Health Organization recommended that antipsychotic agents should be initiated without routinely adding anticholinergic drugs prophylactically. However, combined treatment with antipsychotics and anticholinergic agents is the norm in India. The goal of this study was to investigate whether Indians are more susceptible to extrapyramidal side effects (EPS) or if the practice of routinely adding an anticholinergic agent to an antipsychotic is overly cautious and wasteful. METHOD: 75 consecutive patients started on conventional antipsychotics were repeatedly evaluated over 2 months on a standardized EPS scale, the abbreviated Simpson-Angus scale. RESULTS: Of 71 subjects who completed the study, 68 (96%) suffered EPS while receiving 2-13 mg/day of haloperidol equivalents, with 70% of EPS present by day 5 and 90% by day 10. The most common symptoms were tremor (49%), cogwheel rigidity (40%), and acute dsytonic reaction (34%). Routine clinical care detected 49% of the EPS, patients volunteered a complaint 19% of the time, and relatives reported EPS in 7% of patients. CONCLUSION: Since patients of Indian origin are prone to suffer EPS when taking conventional antipsychotic drugs, initial prophylaxis with antiparkinson agents should perhaps be more carefully considered on a routine basis. Even among atypicals, agents with the least potential to cause EPS should be favored. In all patients treated with antipsychotics, it is imperative to ask directly about and carefully examine for EPS, because few patients will volunteer their complaints.